Integrating long-acting injectable treatment to improve medication adherence among persons living with HIV and opioid use disorder: study protocol

被引：0
|
作者：
Kirsten J. Langdon
Anthony E. Hitch
Alexandra B. Collins
Curt G. Beckwith
Sara Becker
Karen Tashima
Josiah D. Rich
机构：
[1] Rhode Island Hospital,Department of Psychiatry
[2] Alpert Medical School of Brown University,Department of Psychiatry and Human Behavior
[3] Brown-Lifespan Center for Digital Health,Department of Psychology
[4] University of Cincinnati,Department of Epidemiology
[5] Brown University School of Public Health,Center for Dissemination and Implementation Science
[6] Northwestern University,Department of Medicine, Division of Infectious Diseases
[7] Brown University and The Miriam and Rhode Island Hospitals,undefined
来源：
Addiction Science & Clinical Practice | / 18卷
关键词：
Opioid use disorder; HIV; Medications for opioid use disorder; Long-acting injectable medication; Antiretroviral therapy; Antiviral resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Patients’ goals when initiating long-acting injectable buprenorphine treatment for opioid use disorder: findings from a longitudinal qualitative study
    Joanne Neale
    Stephen Parkin
    John Strang
    Substance Abuse Treatment, Prevention, and Policy, 18
  • [22] Patients' goals when initiating long-acting injectable buprenorphine treatment for opioid use disorder: findings from a longitudinal qualitative study
    Neale, Joanne
    Parkin, Stephen
    Strang, John
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2023, 18 (01)
  • [23] Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study
    Grinsztejn, Beatriz
    Torres, Thiago Silva
    Hoagland, Brenda
    Jalil, Emilia Moreira
    Moreira, Ronaldo Ismerio
    O'Malley, Gabrielle
    Shade, Starley B.
    Benedetti, Marcos R.
    Moreira, Julio
    Simpson, Keila
    Pimenta, Maria Cristina
    Veloso, Valdilea Goncalves
    ImPrEP CAB Brasil Study Team
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2023, 9
  • [24] Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder
    Maremmani, Icro
    Dematteis, Maurice
    Gorzelanczyk, Edward J.
    Mugelli, Alessandro
    Walcher, Stephan
    Torrens, Marta
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (17)
  • [25] Long-acting injectable buprenorphine for opioid use disorder: A systematic review of impact of use on social determinants of health
    Martin, Emily
    Maher, Hayley
    McKeon, Gemma
    Patterson, Sue
    Blake, Julie
    Chen, Kai Yang
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 139
  • [26] Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
    Benning, Lorie
    Mantsios, Andrea
    Kerrigan, Deanna
    Coleman, Jenell S.
    Golub, Elizabeth
    Blackstock, Oni
    Konkle-Parker, Deborah
    Philbin, Morgan
    Sheth, Anandi
    Adimora, Adaora A.
    Cohen, Mardge H.
    Seidman, Dominika
    Milam, Joel
    Kassaye, Seble G.
    Taylor, Tonya
    Murray, Miranda
    BMC WOMENS HEALTH, 2020, 20 (01)
  • [27] Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
    Lorie Benning
    Andrea Mantsios
    Deanna Kerrigan
    Jenell S. Coleman
    Elizabeth Golub
    Oni Blackstock
    Deborah Konkle-Parker
    Morgan Philbin
    Anandi Sheth
    Adaora A. Adimora
    Mardge H. Cohen
    Dominika Seidman
    Joel Milam
    Seble G. Kassaye
    Tonya Taylor
    Miranda Murray
    BMC Women's Health, 20
  • [28] Treatment Initiation, Substance Use Trajectories, and the Social Determinants of Health in Persons Living With HIV Seeking Medication for Opioid Use Disorder
    Cook, Ryan R.
    Jaworski, Erin N.
    Hoffman, Kim A.
    Waddell, Elizabeth N.
    Myers, Renae
    Korthuis, P. Todd
    Vergara-Rodriguez, Pamela
    SUBSTANCE ABUSE, 2023, 44 (04) : 301 - 312
  • [29] Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder
    Kotha, Anupama
    Chen, Beatrice A.
    Lewis, Lauren
    Dunn, Shannon
    Himes, Katherine P.
    Krans, Elizabeth E.
    CONTRACEPTION, 2019, 99 (01) : 36 - 41
  • [30] Design and implementation of a prospective cohort study of persons living with and without HIV infection who are initiating medication treatment for opioid use disorder
    Biondi, Breanne E.
    Mohanty, Subhasis
    Vander Wyk, Brent
    Montgomery, Ruth R.
    Shaw, Albert C.
    Springer, Sandra A.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2021, 21
12345